Subscribe To
CTKB / Cytek Biosciences, Inc. (CTKB) CEO Wenbin Jiang on Q2 2022 Results Earnings Call Transcript
Content Topics
Cytek
Biosciences
Inc
CTKB
Wenbin
Jiang
2022
Results
Biosciences
ctkb
Earnings
Transcript
Stock
CTKB News
By Zacks Investment Research
October 31, 2023
Earnings Preview: Cytek Biosciences, Inc. (CTKB) Q3 Earnings Expected to Decline
Cytek Biosciences, Inc. (CTKB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get more_horizontal
By GlobeNewsWire
September 6, 2023
Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference
FREMONT, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced more_horizontal
By Seeking Alpha
August 12, 2023
Cytek Biosciences, Inc. (CTKB) Q2 2023 Earnings Call Transcript
Cytek Biosciences, Inc. (NASDAQ:CTKB ) Q2 2023 Results Conference Call August 8, 2023 4:30 PM ET Company Participants Paul Goodson - IR Wenbin Jiang - more_horizontal
By GlobeNewsWire
July 20, 2023
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
FREMONT, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced more_horizontal
By Seeking Alpha
May 13, 2023
Cytek Biosciences, Inc. (CTKB) Q1 2023 Earnings Call Transcript
Cytek Biosciences, Inc. (NASDAQ:CTKB ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Paul Goodson - Head Investor Relat more_horizontal
By The Motley Fool
May 12, 2023
Why Shares of Cytek Biosciences Dropped This Week
Cytek focuses on cell analysis primarily for research purposes. The company joined the S&P SmallCap 600 Index last month. more_horizontal
By Zacks Investment Research
May 9, 2023
Cytek Biosciences, Inc. (CTKB) Reports Break-Even Earnings for Q1
Cytek Biosciences, Inc. (CTKB) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.03. This compares to earning more_horizontal
By Zacks Investment Research
April 27, 2023
Cytek Biosciences, Inc. (CTKB) Soars 13.4%: Is Further Upside Left in the Stock?
Cytek Biosciences, Inc. (CTKB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate rev more_horizontal